AN OPEN-LABEL, SINGLE-TREATMENT, SINGLE-PERIOD, SINGLE DOSE, CLINICAL PHASE 1 STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF DIPHTHERIA AND TETANUS VACCINE OF M/s CADILA HEALTHCARE LTD., INDIA IN HEALTHY, ADULT, MALE, HUMAN SUBJECTS UNDER FASTING CONDITION
Latest Information Update: 01 Sep 2016
Price :
$35 *
At a glance
- Drugs Diphtheria-tetanus vaccine (Primary)
- Indications Diphtheria; Tetanus
- Focus Adverse reactions
- Sponsors Cadila Healthcare
- 23 Oct 2015 Status changed to completed.
- 19 Feb 2014 New trial record